It’s not a change of topic - it’s a sign that the company was not bluffing when I asked them in October last year as to progress on potency assay work for back and heart, given the horror they were going through with aGVHD. The answer I got then was that the work with CLBP was a lot more advanced than for heart (for the obvious reason that they were then preparing for the back trial to commence).
So I took the patent application on method of treating progressive heart failure which first appeared here a few months ago in someone’s post, as a sign of progress.
Hope this answers your comment.
- Forums
- ASX - By Stock
- MSB
- once approved
once approved, page-47
-
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.16 |
Change
-0.005(0.43%) |
Mkt cap ! $1.330B |
Open | High | Low | Value | Volume |
$1.15 | $1.17 | $1.15 | $483.9K | 417.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 33623 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 689 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 59542 | 1.165 |
8 | 95084 | 1.160 |
7 | 64755 | 1.155 |
8 | 143232 | 1.150 |
4 | 142497 | 1.145 |
Price($) | Vol. | No. |
---|---|---|
1.170 | 2305 | 1 |
1.175 | 82673 | 6 |
1.180 | 155709 | 10 |
1.185 | 37232 | 4 |
1.190 | 41238 | 7 |
Last trade - 10.18am 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online